Leiden iGEM Team returns home with gold medal

8 december 2023
The Leiden iGEM student team ‘Binanox’ won a gold medal at an international competition for organic entrepreneurs in Paris. Not only that, Binanox also won three “special awards” for best website, entrepreneurship and best safety policy, particularly around lab work and the use of genetically modified organisms.

iGEM is an international competition in the field of synthetic biology. Over six thousand students, in three hundred teams from 45 countries try to invent new products and services for industry, environment and health, for example, using synthetic biology. The organizer is Massachusetts Institute of Technology (MIT) in Boston, USA. Leiden teams often score high marks. In 2019, the student team Rapidemic won with a test kit to quickly detect sexual infectious diseases. Rapidemic is now a startup with a branch in innovation center PLNT on Leiden’s Langegracht.

(text continues after photo)

Top ten

Binanox students are developing nanoparticles that can remove tumors in head and neck cancers. All in all, the team finished in the top ten out of more than three hundred teams. The Leiden students invented a new way for bacteria to produce nanoparticles of silver and gold. Patients with head and neck cancer can have those particles injected near a tumor, after which infrared radiation heats the nanoparticles, thus breaking down the tumors.

Mirthe Zandbelt, undergraduate Life Science and Technology student and Binanox team manager, is especially proud of the top-ten place. “It shows that as a team we have achieved something special. At the same time, the three special awards also show that our three managers website, entrepreneurship and safety have also done top work individually.” Thus, a bright future seems up for grabs, but it is not so simple. “There is a lot of potential in Binanox,” says Windi Putri Wulandari, communications manager and master’s student in biology, “But before we can think about that, we need to graduate!”

This news item is a copy of the Leidsch Dagblad article published earlier on December 2, 2022.
Photography: Hielco Kuipers

Share this article

View all latest articles

22 december 2025
Robert Krams develops personalized treatments for every patient using AI
How do you ensure that every patient, regardless of their illness, receives the ...
15 december 2025
how MyClusters is giving people with cluster headaches more control over their health
How do you help people regain control over their lives when they suffer from one...
15 december 2025
From discovery to impact: How Glyco Diagnostics aims to change the fight against liver fibrosis
Glyco Diagnostics is developing an innovative liver fibrosis test to help diabet...
5 december 2025
VINDI Biosystems detects diseases early using photonics
What if we could treat diseases before a patient even experiences a single sympt...
5 december 2025
EMA shares insights on medicines regulation
The European Medicines Agency (EMA) recently joined unlock_ and BioPartner Leide...
28 augustus 2025
How Pulmonavat is shaping the future of lung care
At Pulmonavat, everything revolves around innovation in healthcare. Founder Alic...
28 juli 2025
How unlock_ opens doors for GameAnalyze
At GameAnalyze, everything revolves around the wellbeing of children. With an in...
26 juni 2025
unlock_ hub opening at BioPartner 3!
This month it finally happened: the official opening of the unlock_ hub in the h...
15 april 2025
unlock_ Graduation party 2025!
On April 10th, the participating startups of the PLNT unlock_  program received ...
8 januari 2025
How to set clear goals for your startup
Every successful startup once started small. The difference? They went from drea...
4 december 2024
Meet Idris Oncology: An interview with Hans Peter Mulder
Tell us about yourself and Idris Oncology Hans Peter’s journey...
26 november 2024
3 tips to get you out of your Blue Monday dip
The third Monday of January is known as Blue Monday: the most depressing day of ...